Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 336

Similar articles for PubMed (Select 15611504)

1.

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK.

J Clin Oncol. 2004 Dec 15;22(24):4888-92.

2.

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.

Kushner BH, LaQuaglia MP, Bonilla MA, Lindsley K, Rosenfield N, Yeh S, Eddy J, Gerald WL, Heller G, Cheung NK.

J Clin Oncol. 1994 Dec;12(12):2607-13.

PMID:
7527454
3.

Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.

Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O.

J Clin Oncol. 2005 Jan 20;23(3):532-40.

4.

Dose-intensive use of cyclophosphamide in ablation of neuroblastoma.

Kushner BH, O'Reilly RJ, LaQuaglia M, Cheung NK.

Cancer. 1990 Sep 15;66(6):1095-100.

PMID:
2400963
5.

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.

Kushner BH, Meyers PA, Gerald WL, Healey JH, La Quaglia MP, Boland P, Wollner N, Casper ES, Aledo A, Heller G, et al.

J Clin Oncol. 1995 Nov;13(11):2796-804.

PMID:
7595741
6.

[Evaluation of efficacy of treatment for 30 children with neuroblastoma].

Sun XF, Liu DG, Su YS, Lin TY, Chen XQ, He YJ.

Ai Zheng. 2003 Dec;22(12):1343-5. Chinese.

PMID:
14693065
7.

Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.

Kushner BH, Yeh SD, Kramer K, Larson SM, Cheung NK.

J Clin Oncol. 2003 Mar 15;21(6):1082-6.

PMID:
12637474
8.

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ.

Med Pediatr Oncol. 2001 Jan;36(1):227-30.

PMID:
11464891
9.

Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.

Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.

Cancer. 2002 Sep 15;95(6):1354-65.

10.

Neuroblastoma.

Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.

Saudi Med J. 2001 Aug;22(8):674-80.

PMID:
11573111
11.

NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.

Coze C, Hartmann O, Michon J, Frappaz D, Dusol F, Rubie H, Plouvier E, Leverger G, Bordigoni P, Béhar C, Beck D, Mechinaud F, Bergeron C, Plantaz D, Otten J, Zucker JM, Philip T, Bernard JL.

J Clin Oncol. 1997 Dec;15(12):3433-40.

PMID:
9396394
12.

Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.

Felgenhauer J, Hawkins D, Pendergrass T, Lindsley K, Conrad EU 3rd, Miser JS.

Med Pediatr Oncol. 2000 Jan;34(1):29-38.

PMID:
10611582
15.

Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.

Mastrangelo S, Tornesello A, Diociaiuti L, Pession A, Prete A, Rufini V, Troncone L, Mastrangelo R.

Br J Cancer. 2001 Feb;84(4):460-4.

16.

N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.

Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Bénard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemerle J, Sommelet D.

J Clin Oncol. 1997 Mar;15(3):1171-82.

PMID:
9060561
17.

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.

Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A.

J Clin Oncol. 2001 May 15;19(10):2696-704.

PMID:
11352962
18.
19.

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL.

J Clin Oncol. 2004 Dec 15;22(24):4881-7. Erratum in: J Clin Oncol. 2005 Apr 20;23(12):2877.

20.

Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.

De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero Di Montezemolo L, Donfrancesco A, Pession A, Provenzi M, di Cataldo A, Rizzo A, Tonini GP, Dallorso S, Conte M, Gambini C, Garaventa A, Bonetti F, Zanazzo A, D'Angelo P, Bruzzi P; Italian Co-Operative Group for Neuroblastoma.

J Clin Oncol. 2003 Apr 15;21(8):1592-601.

PMID:
12697885
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk